Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hank

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal AdenocarcinomaDavid J Birnbaum, Sebastian K S Begg, Pascal Finetti, et al.
Frontiers in Genetics|October 7, 2021
Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic AnalysisHiroki Sato, Takeshi Saito, Hiroshi Horii, et al.
Annals of Surgery|November 7, 2024
Alloplastic Vascular Grafts for Venous Interposition in Pancreatic Surgery: Readily Available and ReliableBenedict Kinny-Köster, Arnaud Lambrecht, Viktoria Flossmann, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
Annals of Surgery|July 11, 2020
Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?Oliver Strobel, Philipp Lorenz, Ulf Hinz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1Pei-Yun Tsai, Min-Sik Lee, Unmesh Jadhav, et al.
Annals of Surgery|July 11, 2020
A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-scoreThomas Hank, Marta Sandini, Cristina R Ferrone, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Annals of Surgery|March 5, 2025
Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic CancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal AdenocarcinomaDavid J Birnbaum, Sebastian K S Begg, Pascal Finetti, et al.
Frontiers in Genetics|October 7, 2021
Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic AnalysisHiroki Sato, Takeshi Saito, Hiroshi Horii, et al.
Annals of Surgery|November 7, 2024
Alloplastic Vascular Grafts for Venous Interposition in Pancreatic Surgery: Readily Available and ReliableBenedict Kinny-Köster, Arnaud Lambrecht, Viktoria Flossmann, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
Annals of Surgery|July 11, 2020
Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?Oliver Strobel, Philipp Lorenz, Ulf Hinz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1Pei-Yun Tsai, Min-Sik Lee, Unmesh Jadhav, et al.
Annals of Surgery|July 11, 2020
A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-scoreThomas Hank, Marta Sandini, Cristina R Ferrone, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Annals of Surgery|March 5, 2025
Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic CancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
Pageof 7